News from BAT Research & Development
British American Tobacco’s 2015 Science & Technology Report details significant strides in the science of tobacco harm reduction made by BAT’s R&D department over the last year.
BAT’s Pre-Clinical Assessment Manager, Dr Marinna Gaça, presented on Acute inhalation toxicity: in vitro and ex vivo systems in a webinar covering State-of-the-science, practical application, and dosimetry considerations for in vitro and ex vivo methods.
BAT presented its experience and approach to using biomarkers to assess the reduced-risk potential of novel tobacco and nicotine products at the US Food and Drug Administration’s workshop Biomarkers of Potential Harm (April 4-5).
BAT’s Chief Scientific Officer, Chris Proctor, is in San Diego at the Spring National Meeting of the American Chemical Society. Chris presented at the 2015 Autumn National Meeting in a session on Scientific Integrity. In San Diego, Chris continues his work as a committee member of the Corporate Associates Division.
As part of our open and transparent approach, we have designed an interactive visitor exhibit to showcase our science. Our exhibit room, R&D Live, puts you in direct conversation with our scientists as they explain the concept of their work.